Scientific Program

Thursday, December 7, 2017
Time Topic Session
Registration Sign-In
Opening Remarks
Alphonse E. Sirica, Ph.D., M.S. (VCU) 
SESSION 1: Hepatobiliary Cancer Risk Conditions and Prevention Strategies

Chairs: Anna Mae Diehl, M.D., Hashem B. El-Serag, M.D., M.P.H.
Key Topic Areas: Focus on known risk conditions for primary liver cancers, with added emphasis on prevention strategies.

Time Presentation Title and Speaker* Ϯ
The changing etiology of liver cancer, challenges for the next 20 years

John D. Groopman, Ph.D. (Johns Hopkins)

Prevention of hepatitis C related hepatocellular carcinoma

Hashem B. El-Serag, M.D., M.P.H. (Baylor College of Medicine)

Liver repair and risk for liver cancer

Anna Mae Diehl, M.D. (Duke)

Refreshment Break 
Steatohepatitis accelerates HCC development in mice

Gyongyi Szabo, M.D., Ph.D. (UMass)

Friday, December 8, 2017
Saturday, December 9, 2017
Sunday, December 10, 2017

*Oral presentations by Invited Speakers will be 25 minutes, with an additional 5 minutes for questions. Abstract-driven short talks will be 10 minutes, with 5 additional minutes for questions.

Ϯ Titles of individual oral presentations provided by the Invited Speakers are presumptive and may change to reflect new key basic and translational research findings and biomedical advances.           




Attendees List (updated 12/13/17)


Hepatobiliary Cancers Evaluation Form